Viewing StudyNCT00160706



Ignite Creation Date: 2024-05-05 @ 11:53 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00160706
Status: COMPLETED
Last Update Posted: 2018-08-07
First Post: 2005-09-08

Brief Title: A follow-on Safety Study in Subjects With Crohns Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 NCT00152490 or CDP870-032 NCT00152425 Due to an Exacerbation of Crohns Disease
Sponsor:
Organization: UCB Pharma

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 310
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE3
Observational Models:
Time Perspective List:
Who Masked List: